Fire breaks out at private hospital in Noida; none hurt
Noida: A fire broke out at a private hospital following a short circuit in its physiotherapy unit in Noida, Sector 11, on Wednesday morning, fire officials said, adding that no casualties were reported.
'On Wednesday around 8 am, the fire control room received information from hospital staff that a fire had broken out on the ground floor of the hospital,' said Pradeep Chaubey, chief fire officer of Gautam Budh Nagar.
The CFO said, 'Upon receiving the information, three fire tenders from surrounding fire stations were rushed to the spot, and the flames were brought under control within an hour.'
During the investigation, it came to light that the fire originated in the physiotherapy unit on the ground floor. 'The physiotherapy unit is located at a distance from the main hospital, so it was not necessary to evacuate any patients due to smoke,' said Chaubey, adding that it is suspected some electrical equipment was left late Monday night before the unit was closed.
'The unit was closed when the fire broke out. It is suspected that a short circuit may have caused the fire. No casualties were reported, and hospital staff attempted to contain the fire before firefighters arrived,' Chaubey added.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Indian Express
22 minutes ago
- Indian Express
Do lemons really help migraines? Experts weigh in
Lemon's role in migraine relief Despite popular belief, there's no solid evidence supporting lemons as a cure for migraines. Source: Canva
Hans India
28 minutes ago
- Hans India
Global yoga movement began with PM Modi's vision: Prataprao Jadhav
New Delhi: When the United Nations General Assembly adopted June 21 as the International Day of Yoga in 2014 -- following the visionary call of Prime Minister Narendra Modi -- it marked the beginning of a global wellness movement rooted in India's traditional wisdom, said Union Minister of State for Ayush Ministry, Prataprao Jadhav, on Thursday. Addressing the media during the curtain-raiser event here for the 11th International Day of Yoga (IDY), Jadhav reflected on how IDY has become a worldwide movement. 'From the record-setting first event in the national capital to celebrations in cities like Mysuru, New York, and Srinagar, Yoga has brought together people from across the globe in the pursuit of health and peace,' he said. The curtain-raiser event was held at the National Media Centre here and marked the formal beginning of the IDY 2025 celebrations. The national event this year will be led by PM Modi on June 21 in Visakhapatnam, Andhra Pradesh. Speaking about the significance of this year's event, the Minister said that the 11th edition of IDY is not just a celebration but a call to expand Yoga's reach across society". 'This year's theme, 'Yoga for One Earth, One Health', is in line with the global health vision promoted during India's G20 Presidency and reflects the Indian ideal of 'Sarve Santu Niramaya' -- meaning 'May all be free from disease'," the Union Minister stated. The minister shared that the grand event in Visakhapatnam will see PM Modi leading the common yoga protocol session with over five lakh participants. At the same time, 'Yoga Sangam' sessions will be held at more than one lakh locations across the country, making it one of the biggest synchronised yoga demonstrations ever. He also praised the Andhra Pradesh government and its Chief Minister, N. Chandrababu Naidu, for launching the 'YogaAndhra' campaign. This state-level initiative aims to create a community of 10 lakh regular yoga practitioners. As part of the lead-up to the main event, the Ministry has planned ten signature events over 100 days. These events are designed to engage people from all walks of life and promote yoga as a complete lifestyle. Some of these include 'Yoga Samavesh' for inclusivity and 'Yoga Bandhan' to promote international cooperation.
&w=3840&q=100)
Business Standard
31 minutes ago
- Business Standard
Bharat Biotech signs pact with GSK to develop Shigella vaccine candidate
Bharat Biotech on Thursday announced its partnership with UK-based pharma company GSK for the development and potential use of the Shigella vaccine candidate altSonflex1-2-3. As part of the agreement, Bharat Biotech will lead the further development of altSonflex1-2-3, including Phase 3 clinical trials, regulatory advancement and large-scale manufacturing. GSK, on the other hand, will support the programme by assisting with clinical trial design, securing external funding and contributing to the access and delivery plans and commercialisation strategy. The company said that the agreement marks a significant step in advancing the vaccine, which targets shigellosis, a severe form of bacterial diarrhoea that disproportionately affects children under five years of age in low- and middle-income countries (LMICs). 'The vaccine candidate has already demonstrated a strong safety and immunogenicity profile in both European and African trials, including in the primary target population of nine-month-old infants,' it added. Commenting on the development, Krishna Ella, Executive Chairman at Bharat Biotech, said that with no approved vaccine currently available and antimicrobial resistance on the rise, there is an urgent need for scalable, science-backed solutions focused on LMICs. 'This collaboration combines our strengths in innovation, manufacturing and global health commitment.' According to the World Health Organisation (WHO), Shigella was the second-leading cause of diarrhoeal mortality in 2016 (latest data) among all ages and the leading bacterial cause of diarrhoea, accounting for approximately 212,000 deaths and about 13 per cent of all diarrhoea-associated deaths. The disease is a major contributor to child morbidity and mortality, and the emergence of drug-resistant strains underscores the urgent need for a preventive vaccine. The standard of care for shigellosis primarily involves managing dehydration and using antibiotics. While mild cases often resolve with rest and fluid replacement, more severe cases or those with weakened immune systems may benefit from antibiotics like ciprofloxacin or azithromycin. Thomas Breuer, Chief Global Health Officer at GSK, said that by helping reduce illness and antibiotic use, this vaccine has the potential to play a critical role in combating antimicrobial resistance (AMR). The companies claimed that the vaccine candidate has broad serotype coverage, an innovative Generalised Modules for Membrane Antigens (GMMA)-based platform and robust early clinical results. 'GMMA technology is a platform that uses bacterial outer membranes to deliver the O antigen to the immune system, allowing for high-yield production, which creates affordable vaccines for underserved populations,' they added in a statement.
